Calcitonin gene-related peptide (CGRP) acts independently of calcitonin on cyclic AMP formation in clonal osteogenic sarcoma cells (UMR 106-01)
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
In several human cancer cell lines and in a subclone of rat osteogenic sarcoma cells (UMR 106-06) possessing calcitonin receptors and a calcitonin-responsive adenylate cyclase, calcitonin gene-related peptide (CGRP) behaved as a weak calcitonin agonist. In another subclone of the same osteogenic sarcoma (UMR 106-01) with no measurable calcitonin receptors or response, both rat and human CGRP were found to increase cyclic AMP formation in a dose-dependent manner. The data indicate that CGRP is capable of a weak calcitonin-like action in cells with calcitonin receptors, but also that in some cells CGRP activates adenylate cyclase itself, independently of calcitonin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CGRP treatment increased cAMP levels in the UMR 106-01 rat osteosarcoma cell line and in other osteoblastic cell lines and primary osteoblast cultures (18,148,200).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [148]
Citations
Cites
A highly sensitive adenylate cyclase assay
Salomon, Y., Londos, C., & Rodbell, M. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90222-x · Cited by 4,169 · cited 1×
“After standing at 4~ for 1 hour, the [3H] cyclic AMP generated was isolated by sequential chromatography on Dowex and alumina columns [18].”
MethodProduction of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302 · cited 1×
“Tissue-specific R N A processing de t e rmines w h e t h e r ca lc i ton in or C G R P is produced [5], and C G R P has been located by immunocy tochemis t ry in a n u m b e r of cell groups in the central and per iphera l ne rvous sys t ems [5].”
BackgroundAmara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Calcitonin gene-related peptide is a potent vasodilator
Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R., & MacIntyre, I. (1985) · Nature · doi:10.1038/313054a0 · Cited by 2,086 · cited 1×
“In addition to its location in the nervous system and possible transmitter role there, CGRP has been found to have potent effects on the heart [3] and to be an extremely potent vasodilator, capable of affecting the microvasculature and large arteries [19].”
BackgroundParathyroid Hormone-Responsive Clonal Cell Lines from Rat Osteosarcoma*
MAJESKA, R. J., RODAN, S. B., & RODAN, G. A. (1980) · Endocrinology · doi:10.1210/endo-107-5-1494 · Cited by 473
Isolation and characterization of human calcitonin gene-related peptide
Morris, H. R., Panico, M., Etienne, T., Tippins, J., Girgis, S. I., & MacIntyre, I. (1984) · Nature · doi:10.1038/308746a0 · Cited by 424 · cited 2×
“In addition to its location in the nervous system and possible transmitter role there, CGRP has been found to have potent effects on the heart [ 3 ] and to be an extremely potent vasodilator, capable of affecting the microvasculature and large arteries [19].”
BackgroundMethodA second human calcitonin/CGRP gene
Steenbergh, P. H., Höppener, J. W. M., Zandberg, J., Lips, C. J. M., & Jansz, H. S. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80820-6 · Cited by 364 · cited 1×
“Key words: Calcitonin gene-related peptide -- Adenylate cyclase -- Rat osteogenic sarcoma --Human cancer cells. calcitonin gene [ 4 ].”
BackgroundPartridge, N. C., Alcorn, D., Michelangeli, V. P., Ryan, G. B., & Martin, T. J. (1983) · PubMed · Cited by 310
Self-citationInteraction of Calcitonin and Calcitonin Gene-Related Peptide at Receptor Sites in Target Tissues
Goltzman, D., & Mitchell, J. (1985) · Science · doi:10.1126/science.2983422 · Cited by 286 · cited 2×
“This would be consistent with the observations of Goltzman and Mitchell [7] who showed that in membrane preparations of several target tissues in the rat, CGRP acted as a weak calcitonin-like agonist on adenylate cyclase, but did not appear to stimulate adenylate cyclase in its own specific targets.”
ResultTschopp, F. A., Henke, H., Petermann, J. B., Tobler, P. H., Janzer, R., Hökfelt, T., Lundberg, J. M., Cuello, C., & Fischer, J. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.248 · Cited by 279 · cited 4×
“Furthermore, specific binding of CGRP has been demonstrated to sites in the brain and spinal cord [6].”
BackgroundResultInfluential
Research works printed but not linked: 1
- Findlay DM, Michelangeli VP, Eisman JA, Michelangeli VP, Moseley JM, Partridge NC (1980) Calcitonin receptors in a cloned human breast cancer cell line (MCF 7). Biochem Biophys Res Commun 90: 150–156
Cited by
Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37)
Chiba, T., Yamaguchi, A., Yamatani, T., Nakamura, A., Morishita, T., Inui, T., Fukase, M., Noda, T., & Fujita, T. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.2.e331 · Cited by 360
Togari, A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10121 · Cited by 213
Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats
Hill, E. L., Turner, R., & Elde, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90094-5 · Cited by 192
Pfeilschifter, J., Diel, I., Pilz, U., Brunotte, K., Naumann, A., & Ziegler, R. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080609 · Cited by 174
Bjurholm, A., Kreicbergs, A., Schultzberg, M., & Dr. Lerner, U. H. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070903 · Cited by 145
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“CGRP treatment increased cAMP levels in the UMR 106-01 rat osteosarcoma cell line and in other osteoblastic cell lines and primary osteoblast cultures (18, 148, 200).”
BackgroundNeuroendocrine peptides in bone
Bjurholm, A. (1991) · International Orthopaedics · doi:10.1007/bf00186871 · Cited by 150
Irie, K., Hara‐Irie, F., Ozawa, H., & Yajima, T. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10122 · Cited by 135
Comparison of the Effects of Calcitonin Gene-Related Peptide and Amylin on Osteoblasts
Dr. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Gamble, G. D., Cooper, G. J. S., & Reid, I. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1302 · Cited by 121
Hara‐Irie, F., Amizuka, N., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00425-4 · Cited by 123
Effects of CGRP, forskolin, PMA, and ionomycin on pHi dependence of Na-H exchange in UMR-106 cells
Gupta, A., Schwiening, C. J., & Boron, W. F. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.4.c1083 · Cited by 100
Lerner, U. H., & Persson, E. (2008) · PubMed · Cited by 112
Commonly used mouse models of osteosarcoma
Ek, E. T., Dass, C. R., & Choong, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.03.006 · Cited by 87
Drissi, H., Lasmoles, F., Mellay, V. L., Marie, P. J., & Lieberherr, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20168 · Cited by 91
Michelangeli, V. P., Fletcher, A. E., Allan, E. H., Nicholson, G. C., & Martin, T. J. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040220 · Cited by 78
Self-citationCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Neuropeptidergic regulation of bone resorption and bone formation.
Lerner, U. H. (2002) · PubMed · Cited by 85
A mechanism for sympathectomy-induced bone resorption in the middle ear
SHERMAN, B., & Chole, R. A. (1995) · Otolaryngology · doi:10.1016/s0194-5998(95)70048-x · Cited by 57
Clinical and Preclinical Rationale for CGRP‐Receptor Antagonists in the Treatment of Migraine
Tepper, S. J., & Stillman, M. J. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01214.x · Cited by 51
Pasteurella multocida toxin is a mitogen for bone cells in primary culture
Mullan, P. B., & Lax, A. J. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.959-965.1996 · Cited by 50
Emerging neuroskeletal signalling pathways: a review
Spencer, G. J., Hitchcock, I. S., & Genever, P. G. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00053-5 · Cited by 53
Sakagami, Y., Girasole, G., Yu, X.-P., Boswell, H. S., & Manolagas, S. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080706 · Cited by 46
Structure-activity relationship of human calcitonin-gene-related peptide
Zaidi, M., Brain, S. D., Tippins, J. R., Marzo, V. D., Moonga, B. S., Chambers, T. J., Morris, H. R., & MacIntyre, I. (1990) · Biochemical Journal · doi:10.1042/bj2690775 · Cited by 50
Mechanism of action of amylin in bone
Tamura, T., Miyaura, C., Owan, I., & Suda, T. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530103 · Cited by 42
Drissi, H., Hott, M., Marie, P. J., & Lasmoles, F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1805 · Cited by 42
Human placental calcitonin receptors
Nicholson, G. C., D'Santos, C. S., Evans, T., Moseley, J. M., Kemp, B. E., Michelangeli, V. P., & Martin, T. J. (1988) · Biochemical Journal · doi:10.1042/bj2500877 · Cited by 41
Self-citationThiebaud, D., Akatsu, T., Yamashita, T., Suda, T., Noda, T., Martin, R. E., Fletcher, A. E., & Prof. Martin, T. J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061016 · Cited by 36
Self-citationThe early effects of surgical sympathectomy on bone resorption in the rat incisor socket
Sandhu, H. S., Kwong-Hing, A., Herskovits, M. S., & Singh, I. J. (1990) · Archives of Oral Biology · doi:10.1016/0003-9969(90)90020-b · Cited by 33
Richter, J., Andersson, R., Edvinsson, L. I., & Gullberg, U. (1992) · PubMed Central · Cited by 32
Kinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Kawase, T., Howard, G. A., Roos, B. A., & Burns, D. M. (1995) · Bone · doi:10.1016/s8756-3282(95)80457-9 · Cited by 30
Kawase, T., & Burns, D. M. (1998) · Endocrinology · doi:10.1210/endo.139.8.6151 · Cited by 30
Wimalawansa, S. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22758.x · Cited by 27
Hamada, H., Kitamura, K., Chosa, E., Eto, T., & Tajima, N. (2002) · Peptides · doi:10.1016/s0196-9781(02)00259-0 · Cited by 16
Bársony, J., & Marx, S. J. (1988) · Endocrinology · doi:10.1210/endo-122-4-1218 · Cited by 16
Calcitonin Gene Products: Molecular Biology, Chemistry, and Actions
Born, W., & Fischer, J. A. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_16 · Cited by 15
Zaidi, M., Datta, H. K., Chambers, T. J., & Macintyre, I. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80200-1 · Cited by 14
Kinins and Neuro-osteogenic Factors
Lerner, U. H., & Lundberg, P. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50146-3 · Cited by 17
Hu, S., Yang, L., Wu, C., & Liu, T.-Y. (2019) · Physiology International · doi:10.1556/2060.106.2019.07 · Cited by 9
Findlay, D. M., Houssami, S., Christopoulos, G., & Sexton, P. M. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895320 · Cited by 9
Self-citationvan Valen, F., KECK, E., & Jürgens, H. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81742-9 · Cited by 8
Radioreceptor assay for formulations of salmon calcitonin
Sjödin, L., Nederman, T., Pråhl, M., & Montelius, K. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90163-x · Cited by 6
Naot, D., Musson, D. S., & Cornish, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00033-6 · Cited by 4
Trentz, O. A., Uhlschmid, G. K., & Bösch, C. (2001) · European Journal of Trauma · doi:10.1007/s00068-001-1053-3 · Cited by 3
Amylin and Calcitonin Gene-Related Peptide
Naot, D., Reid, I. R., & Cornish, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00056-2 · Cited by 2
Other Factors Controlling Bone Growth and Development
Cornish, J., & Martin, T. J. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50010-5
Self-citationAmylin and Calcitonin Gene-Related Peptide
Reid, I. R., & Cornish, J. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50138-4
Metadata
- Authors
- Michelangeli, V. P., Findlay, D. M., Fletcher, A., & Martin, T. J.
- Affiliations
- The University of Melbourne (AU)
- ORCID
- Findlay, D. M.
- Venue
- Calcified Tissue International
- Published
- 1986-03
- Volume
- 39
- Issue
- 1
- Pages
- 44-48
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2015852167
- Semantic Scholar
- 0f1f162ee3c7b37cdf90ffebbf0d3b4b20d64b72
- Cited by
- 49
- References
- 22
- Citations by year
- 2020: 1 · 2019: 2 · 2018: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- calcitonin gene-related peptide, calcitonin, cyclic AMP, adenylate cyclase, calcitonin receptor, osteosarcoma, UMR 106-01 cells, receptor-independent signaling
- MeSH terms
- Cyclic AMP, Animals, Calcitonin, Clone Cells, Dose-Response Relationship, Drug, Drug Synergism, Humans, Nerve Tissue Proteins, Osteosarcoma, Calcitonin Gene-Related Peptide, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.